Monthly Archives: March 2012

Supreme Court Reverses In Prometheus v. Mayo!

In a decision dated March 20, 2012, Justice Breyer writing for a unanimous court, held that claims to administering a drug, followed by measuring the levels of metabolites of the drug, in order to optimize the amount administered, are not patent … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 8 Comments

Happy Birthday To Me – Patents4Life is Three!

Three years ago, when I started this Blog (or is it “Blawg”?), the hot topics were In re Kubin and the summary affirmance of Classen by the Fed. Cir. Today, along with the looming AIA regulations, Mayo v. Prometheus and … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | 1 Comment

A Hidden Danger Under The EPC – The “Extension Trap”

Provided to us by Dr. Stefan Danner of DHS Patentanwalts GmbH, find below the current issue of the biotech IP newsletter dealing with recent EPO case law on Article 123(2)(3) EPC. Extension Trap

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment